Loading…
HEMGENIX is a one-time gene therapy for adults with hemophilia B who currently use Factor IX prophylaxis or have life-threatening bleeding. It is administered as a single intravenous infusion and can eliminate the need for prophylaxis by enabling the body to produce its own Factor IX.
AI named Hemgenix in October 2025.